Sentinus LLC’s Ultralife ULBI Stock Holding History

Sentinus LLC’s Portfolio ULBI Stock Details ULBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-70,000	Closed	-$400K	–	661
2025 Q4	$400K	Buy	+70,000	New	+$432K	0.04%	359

Other funds holding ULBI

VWA

Visionary Wealth Advisors O'fallon, Illinois $2.26B AUM 19.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

THC

Truffle Hound Capital Bethesda, Maryland $386M AUM 57.88% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Sentinus LLC's ULBI Position: Q1 2026 in Review

Sentinus LLC sold out of Ultralife (ULBI) in Q1 2026, closing a stake of 70,000 shares — an estimated $400K sold.

Sentinus LLC first reported a position in ULBI in Q4 2025 and held it in 1 quarter. The position peaked at $400K in Q4 2025. 50 funds tracked by Wall St. Rank hold ULBI as of Q1 2026.

Sentinus LLC reported no remaining Ultralife position as of Q1 2026 after selling out during the quarter.
Sentinus LLC sold 70,000 Ultralife shares in Q1 2026, an estimated $400K.
Sentinus LLC first reported a position in Ultralife in Q4 2025 and held it in 1 quarter.
Sentinus LLC's Ultralife position peaked at $400K in Q4 2025.
50 funds tracked by Wall St. Rank held Ultralife as of Q1 2026.

Based on Sentinus LLC's 13F filing for Q1 2026, filed 6 May 2026.